allergy relief — Class II drug recall D-0910-2023
Terminated recall by L. Perrigo Company, reported 2023-07-19, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0910-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | L. Perrigo Company, Allegan, MI, United States |
| Recall initiated | 2023-02-09 |
| Classified | 2023-07-11 |
| Reported by FDA | 2023-07-19 |
| Terminated | 2023-09-11 |
| Distributed | Nationwide (US) |
| Quantity | 208,416 cartons |
| Reason classes | specification failure |
| NDC | 11673-0617-01, 11673-0617-22, 11673-0617-39, 11673-0617-47 |
Product
allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0910-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.